The incorporation of CaO2 nanoparticles further alleviates tumor hypoxia, creating a favorable microenvironment for the synergistic effects of ROS modulation and ZBP1 regulation, thereby enhancing both tumor therapy and bone regeneration. This evidence concerns the gene ZBP1 and neoplasm.